Jantip Pornpat Aom, Singh Chandra K, Klu Yaa Asantewaa Kafui, Ahmad Nihal, Bolling Bradley W
Department of Food Science, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Department of Dermatology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, USA.
J Food Sci. 2025 Feb;90(2):e70018. doi: 10.1111/1750-3841.70018.
Increased consumption of nuts is associated with reduced risk of some forms of cancer, including leukemia. Peanut skins are not typically retained during food processing but are a potential source of anticarcinogenic polyphenols. There are limited data about the antileukemic activity and bioavailability of peanut skin polyphenols. This study determined the polyphenol profile of raw peanut skin extract (PSE), its antiproliferative activity toward Jurkat cells, and intestinal bioavailability and metabolism using a Caco-2 intestinal monolayer model. High-resolution mass spectrometry (UHPLC-Q-Orbitrap) was used to analyze PSE and extracts of PSE-treated Jurkat cells to determine PSE polyphenols associated with antiproliferative activity. PSE reduced Jurkat cell viability, indicating its antiproliferative activity. PSE contained at least 63 polyphenols, including phenolic acids, proanthocyanidins, and prenylated flavonoids, among others. Multiple PSE polyphenols, particularly proanthocyanidins with A-type bonds, interacted with Jurkat cells. In Caco-2 cells, PSE intestinal bioavailability was limited to (+)-catechin, quercetin, procyanidin A2, and tentatively procyanidin A1. Caco-2 cells metabolized PSE polyphenols, including the methylation of A-type procyanidin dimer. Thus, these cell-based studies demonstrate that raw peanut skins contain intestinal bioavailable polyphenols with potential antileukemic properties. PSE polyphenols, including A-type proanthocyanidins, were metabolized by intestinal cells. Thus, the antileukemic activity of PSE polyphenols is modulated by the bioavailability and metabolism of A-type proanthocyanidins. PRACTICAL APPLICATION: Raw peanut skins are rich in polyphenols, including A-type proanthocyanidins. Extracts of peanut skins inhibit the growth of cultured leukemia cells, and peanut A-type proanthocyanidins are associated with this effect. Peanut skins are not typically retained in food processing, so further research and development are needed to recover or retain these compounds and document their health-promoting activities in human research studies.
食用坚果量的增加与包括白血病在内的某些癌症风险降低有关。花生皮在食品加工过程中通常不会保留,但它是抗癌多酚的潜在来源。关于花生皮多酚的抗白血病活性和生物利用度的数据有限。本研究使用Caco-2肠单层模型确定了生花生皮提取物(PSE)的多酚谱、其对Jurkat细胞的抗增殖活性以及肠道生物利用度和代谢情况。使用高分辨率质谱(UHPLC-Q-Orbitrap)分析PSE和经PSE处理的Jurkat细胞提取物,以确定与抗增殖活性相关的PSE多酚。PSE降低了Jurkat细胞活力,表明其具有抗增殖活性。PSE至少含有63种多酚,包括酚酸、原花青素和异戊烯基黄酮等。多种PSE多酚,特别是具有A型键的原花青素,与Jurkat细胞相互作用。在Caco-2细胞中,PSE的肠道生物利用度仅限于(+)-儿茶素、槲皮素、原花青素A2,以及初步确定的原花青素A1。Caco-2细胞代谢PSE多酚,包括A型原花青素二聚体的甲基化。因此,这些基于细胞的研究表明,生花生皮含有具有潜在抗白血病特性的肠道可生物利用多酚。PSE多酚,包括A型原花青素,被肠道细胞代谢。因此,PSE多酚的抗白血病活性受到A型原花青素的生物利用度和代谢的调节。实际应用:生花生皮富含多酚,包括A型原花青素。花生皮提取物可抑制培养的白血病细胞生长,花生A型原花青素与这种作用有关。花生皮在食品加工过程中通常不会保留,因此需要进一步研究和开发以回收或保留这些化合物,并在人体研究中记录它们的健康促进活性。